Inloggad som:
BiTe CC93269-MM-001
Är du som patient intresserad av mer information om en studie, kontakta din behandlande läkare.
BiTe CC93269-MM-001
A PHASE 1, OPEN-LABEL, DOSE FINDING STUDY OF CC-93269, A BCMA X CD3 T CELL ENGAGING ANTIBODY, IN SUBJECTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA
A PHASE 1, OPEN-LABEL, DOSE FINDING STUDY OF CC-93269, A BCMA X CD3 T CELL ENGAGING ANTIBODY, IN SUBJECTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA
PLACEHOLDER
Mer information om studien för vårdgivare
Studien ändrades senast av: Caroline Brav (2020-12-02)